These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 28522454)

  • 1. Multiomic disease signatures converge to cytotoxic CD8 T cells in primary Sjögren's syndrome.
    Tasaki S; Suzuki K; Nishikawa A; Kassai Y; Takiguchi M; Kurisu R; Okuzono Y; Miyazaki T; Takeshita M; Yoshimoto K; Yasuoka H; Yamaoka K; Ikeura K; Tsunoda K; Morita R; Yoshimura A; Toyoshiba H; Takeuchi T
    Ann Rheum Dis; 2017 Aug; 76(8):1458-1466. PubMed ID: 28522454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lesional CD4+ IFN-γ+ cytotoxic T lymphocytes in IgG4-related dacryoadenitis and sialoadenitis.
    Maehara T; Mattoo H; Ohta M; Mahajan VS; Moriyama M; Yamauchi M; Drijvers J; Nakamura S; Stone JH; Pillai SS
    Ann Rheum Dis; 2017 Feb; 76(2):377-385. PubMed ID: 27358392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are cytotoxic effector cells changes in peripheral blood of patients with Sjögren's syndrome related to persistent virus infection: Suggestions and conundrums.
    Narkeviciute I; Sudzius G; Mieliauskaite D; Mackiewicz Z; Butrimiene I; Viliene R; Dumalakiene I
    Cell Immunol; 2016 Dec; 310():123-130. PubMed ID: 27592028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the crosstalk molecular mechanisms between IgA nephropathy and Sjögren's syndrome based on comprehensive bioinformatics and immunohistochemical analyses.
    He P; Wei L; Zhang R; Zhao J; Zhang Y; Huang L; Bai X; Ning X; Sun S
    Clin Exp Med; 2024 Aug; 24(1):188. PubMed ID: 39136821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cell-mediated immunity in patients with Sjogren's syndrome].
    Krejsek J; Slezák R; Kopecký O; Vokurková D; Loudová M; Derner V
    Cas Lek Cesk; 1997 Jan; 136(2):44-7. PubMed ID: 9147852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of drug targets for Sjögren's syndrome: multi-omics Mendelian randomization and colocalization analyses.
    Bai Y; Wang J; Feng X; Xie L; Qin S; Ma G; Zhang F
    Front Immunol; 2024; 15():1419363. PubMed ID: 38933282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential localization of CD8+ alpha E beta 7+ T cells around acinar epithelial cells with apoptosis in patients with Sjögren's syndrome.
    Fujihara T; Fujita H; Tsubota K; Saito K; Tsuzaka K; Abe T; Takeuchi T
    J Immunol; 1999 Aug; 163(4):2226-35. PubMed ID: 10438965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diminished expression of CD59 on activated CD8+ T cells undergoing apoptosis in systemic lupus erythematosus and Sjögren's syndrome.
    Tsunoda S; Kawano M; Koni I; Kasahara Y; Yachie A; Miyawaki T; Seki H
    Scand J Immunol; 2000 Mar; 51(3):293-9. PubMed ID: 10736099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laser microdissection coupled with RNA-seq reveal cell-type and disease-specific markers in the salivary gland of Sjögren's syndrome patients.
    Tandon M; Perez P; Burbelo PD; Calkins C; Alevizos I
    Clin Exp Rheumatol; 2017; 35(5):777-785. PubMed ID: 28421997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different La/SS-B mRNA isoforms are expressed in salivary gland tissue of patients with primary Sjögren's syndrome.
    Bachmann M; Hilker M; Grölz D; Tellmann G; Hake U; Kater L; de Wilde P; Tröster H
    J Autoimmun; 1996 Dec; 9(6):757-66. PubMed ID: 9115578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide DNA methylation patterns in naive CD4+ T cells from patients with primary Sjögren's syndrome.
    Altorok N; Coit P; Hughes T; Koelsch KA; Stone DU; Rasmussen A; Radfar L; Scofield RH; Sivils KL; Farris AD; Sawalha AH
    Arthritis Rheumatol; 2014 Mar; 66(3):731-9. PubMed ID: 24574234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cDNA microarray analysis identifies NR4A2 as a novel molecule involved in the pathogenesis of Sjögren's syndrome.
    Takahashi H; Tsuboi H; Asashima H; Hirota T; Kondo Y; Moriyama M; Matsumoto I; Nakamura S; Sumida T
    Clin Exp Immunol; 2017 Oct; 190(1):96-109. PubMed ID: 28621822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature.
    Teruel M; Barturen G; Martínez-Bueno M; Castellini-Pérez O; Barroso-Gil M; Povedano E; Kerick M; Català-Moll F; Makowska Z; Buttgereit A; ; ; Pers JO; Marañón C; Ballestar E; Martin J; Carnero-Montoro E; Alarcón-Riquelme ME
    Sci Rep; 2021 Dec; 11(1):23292. PubMed ID: 34857786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro-inflammatory cytokines enhance ERAD and ATF6α pathway activity in salivary glands of Sjögren's syndrome patients.
    Barrera MJ; Aguilera S; Castro I; Cortés J; Bahamondes V; Quest AFG; Molina C; González S; Hermoso M; Urzúa U; Leyton C; González MJ
    J Autoimmun; 2016 Dec; 75():68-81. PubMed ID: 27461470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant IL-35 levels in patients with primary Sjogren's syndrome.
    Guo J; Gu M; Zhang W; Liu Y; Qian C; Deng A
    Scand J Immunol; 2018 Nov; 88(5):e12718. PubMed ID: 30589451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic and functional abnormalities in the peripheral blood T-cells of patients with primary Sjogren's syndrome.
    Aziz KE; McCluskey PJ; Wakefield D
    Cytometry; 1994 Mar; 18(1):35-41. PubMed ID: 8082485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion of CD4+CD25-GITR+ regulatory T-cell subset in the peripheral blood of patients with primary Sjögren's syndrome: correlation with disease activity.
    Alunno A; Nocentini G; Bistoni O; Petrillo MG; Bartoloni Bocci E; Ronchetti S; Lo Vaglio E; Riccardi C; Gerli R
    Reumatismo; 2012 Dec; 64(5):293-8. PubMed ID: 23256104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4(-)CD8(-) T-cells in primary Sjögren's syndrome: association with the extent of glandular involvement.
    Alunno A; Carubbi F; Bistoni O; Caterbi S; Bartoloni E; Bigerna B; Pacini R; Beghelli D; Cipriani P; Giacomelli R; Gerli R
    J Autoimmun; 2014 Jun; 51():38-43. PubMed ID: 24461537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a new regulatory CD4+ T cell subset in primary Sjögren's syndrome.
    Alunno A; Petrillo MG; Nocentini G; Bistoni O; Bartoloni E; Caterbi S; Bianchini R; Baldini C; Nicoletti I; Riccardi C; Gerli R
    Rheumatology (Oxford); 2013 Aug; 52(8):1387-96. PubMed ID: 23674818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium influx kinetics, and the features of potassium channels of peripheral lymphocytes in primary Sjögren's syndrome.
    Legány N; Toldi G; Orbán C; Megyes N; Bajnok A; Balog A
    Immunobiology; 2016 Nov; 221(11):1266-72. PubMed ID: 27346388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.